Reata Pharmaceuticals Inc (RETA) Puts Out Positive PAH Data – What’s Next?

Reata Pharmaceuticals Inc (NASDAQ:RETA) just announced data from an interim study of its lead blood pressure study, and they company has picked up a bit...

Keep Reading →